Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 22% ± 5% | |
| oligodendrocyte | 11 studies | 36% ± 18% | |
| astrocyte | 8 studies | 33% ± 16% | |
| epithelial cell | 7 studies | 32% ± 18% | |
| microglial cell | 6 studies | 27% ± 9% | |
| ciliated cell | 6 studies | 22% ± 10% | |
| oligodendrocyte precursor cell | 6 studies | 41% ± 16% | |
| fibroblast | 5 studies | 22% ± 4% | |
| basal cell | 5 studies | 22% ± 3% | |
| macrophage | 5 studies | 23% ± 7% | |
| B cell | 4 studies | 18% ± 4% | |
| GABAergic neuron | 4 studies | 41% ± 23% | |
| smooth muscle cell | 4 studies | 16% ± 1% | |
| natural killer cell | 3 studies | 18% ± 2% | |
| classical monocyte | 3 studies | 25% ± 8% | |
| mast cell | 3 studies | 25% ± 6% | |
| retina horizontal cell | 3 studies | 17% ± 2% | |
| Mueller cell | 3 studies | 20% ± 2% | |
| glutamatergic neuron | 3 studies | 58% ± 22% | |
| goblet cell | 3 studies | 18% ± 3% | |
| pericyte | 3 studies | 19% ± 2% | |
| type I pneumocyte | 3 studies | 18% ± 2% | |
| adipocyte | 3 studies | 21% ± 4% | |
| interneuron | 3 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3061.40 | 1445 / 1445 | 100% | 27.51 | 183 / 183 |
| lung | 100% | 3745.78 | 578 / 578 | 100% | 27.92 | 1155 / 1155 |
| ovary | 100% | 5748.97 | 180 / 180 | 100% | 20.94 | 430 / 430 |
| prostate | 100% | 4474.98 | 245 / 245 | 100% | 29.10 | 502 / 502 |
| stomach | 100% | 2967.36 | 359 / 359 | 100% | 27.04 | 286 / 286 |
| intestine | 100% | 3626.98 | 966 / 966 | 100% | 26.52 | 526 / 527 |
| bladder | 100% | 3848.76 | 21 / 21 | 100% | 24.31 | 503 / 504 |
| uterus | 100% | 4926.05 | 170 / 170 | 100% | 21.95 | 458 / 459 |
| kidney | 100% | 3251.94 | 89 / 89 | 100% | 31.50 | 899 / 901 |
| breast | 100% | 4263.20 | 459 / 459 | 100% | 27.79 | 1115 / 1118 |
| thymus | 100% | 5043.17 | 653 / 653 | 100% | 32.73 | 603 / 605 |
| adrenal gland | 100% | 3675.78 | 258 / 258 | 100% | 22.49 | 229 / 230 |
| pancreas | 100% | 2893.12 | 328 / 328 | 99% | 27.14 | 177 / 178 |
| brain | 99% | 1924.05 | 2621 / 2642 | 100% | 28.83 | 705 / 705 |
| liver | 100% | 1778.03 | 226 / 226 | 98% | 16.59 | 397 / 406 |
| skin | 100% | 2693.75 | 1808 / 1809 | 97% | 24.77 | 456 / 472 |
| adipose | 100% | 3890.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3538.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3586.07 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.04 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.01 | 1 / 1 |
| heart | 99% | 1776.11 | 852 / 861 | 0% | 0 | 0 / 0 |
| muscle | 97% | 1152.75 | 778 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 11.38 | 27 / 29 |
| eye | 0% | 0 | 0 / 0 | 93% | 15.41 | 74 / 80 |
| peripheral blood | 66% | 1130.22 | 617 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| Gene name | GATAD1 |
| Protein name | GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein) GATA zinc finger domain-containing protein 1 |
| Synonyms | ODAG |
| Description | FUNCTION: Component of some chromatin complex recruited to chromatin sites methylated 'Lys-4' of histone H3 (H3K4me), with a preference for trimethylated form (H3K4me3). . |
| Accessions | ENST00000645746.1 ENST00000287957.5 Q8WUU5 A0A2R8Y4H1 |